Eran Ophir, the President and CEO of $CGEN, sold 5,625 shares of the company on 04-01-2026 for an estimated $12,412. We received data on the trade from a recent SEC filing. This was a sale of approximately 33.1% of their shares of this class of stock. Following this trade, they now own 11,375 shares of this class of $CGEN stock.
$CGEN Insider Trading Activity
$CGEN insiders have traded $CGEN stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CGEN stock by insiders over the last 6 months:
- ZURIT LEVINE (SVP, Business Development) sold 11,875 shares for an estimated $24,187
- ERAN OPHIR (President and CEO) sold 5,625 shares for an estimated $12,412
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CGEN Hedge Fund Activity
We have seen 20 institutional investors add shares of $CGEN stock to their portfolio, and 27 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 1,020,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,560,600
- STONEPINE CAPITAL MANAGEMENT, LLC added 305,400 shares (+inf%) to their portfolio in Q4 2025, for an estimated $467,262
- ATOM INVESTORS LP removed 226,171 shares (-68.4%) from their portfolio in Q4 2025, for an estimated $346,041
- SQUAREPOINT OPS LLC removed 171,544 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $262,462
- SILVERARC CAPITAL MANAGEMENT, LLC added 168,640 shares (+5.1%) to their portfolio in Q4 2025, for an estimated $258,019
- MILLENNIUM MANAGEMENT LLC removed 141,033 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $215,780
- TWO SIGMA INVESTMENTS, LP added 106,068 shares (+53.6%) to their portfolio in Q4 2025, for an estimated $162,284
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CGEN Analyst Ratings
Wall Street analysts have issued reports on $CGEN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 01/07/2026
To track analyst ratings and price targets for $CGEN, check out Quiver Quantitative's $CGEN forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
